Living meta-analysis and evidence synthesis of therapies for COVID-19

click on circles to display study description...

Xia (66), 2020 ChiCTR2000032459

Sinopharm Beijing (BBIBP-CorV) (n=-9) vs. placebo (n=-9)

randomized controlled trial   risk of bias NA

Studied treatment

Control treatment

placebo

Patients

COVID-19 prophylaxis (excluding children)

Method

double-blind

China

phase 1/2

Remark